Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis (Q39307676)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis |
scientific article |
Statements
1 reference
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis (English)
1 reference
D C Metz
1 reference
C W Howden
1 reference
M C Perez
1 reference
L Larsen
1 reference
J O'Neil
1 reference
S N Atkinson
1 reference
7 February 2009
1 reference
1 reference
1 reference
Identifiers
1 reference